Stay tuned and follow the latest
developments and news in Molecular Oncology.
The poster of the study conducted by Genekor’s Scientific Team “Different Copy Number Variations (CNVs) account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing” […]
Read More
Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene genetic test she performed at Genekor. Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene […]
Read More
NGS PLATFORM – ITS CONTRIBUTION TO CLINICAL PRACTICE In recent years, Next Generation Sequencing (NGS) technologyhas been actively introduced into clinical practice,playing an essential role in understandingthe genetics of many […]
Read More
Genekor’s scientific team, from the very first days of its establishment, has focused on the use and development of new technologies and the quality of services provided. In this way […]
Read More
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer • First results from the independent SWOG […]
Read More
PrIMe – “Precision Individualized Medicine”The new Genekor Medical S.A. PrIMe gene test with 500+ genes and the biomarkers MSI, TBM and PD-L1 in patients with solid tumors has been officially […]
Read More
The use of TMB mutation load detection as a biomarker for the selection of pembrolizumab (Keytruda™) as a treatment for adult and pediatric patients with unresectable or metastatic solid tumors […]
Read More
Every human body is different. So a pharmaceutical substance cannot have the same effect on all people. A treatment may be highly beneficial for one person and for another it […]
Read More
COMMUNITIES MAKE THE DIFFERENCE Each year, on 1 December, the world commemorates World AIDS Day. People around the world unite to show support for people living with HIV and to […]
Read More